Windlas Biotech - Quaterly Results

11 Feb 2025 Evaluate
The revenue for the December 2024 quarter is pegged at Rs. 1950.19 millions, about 20.22% up against Rs. 1622.13 millions recorded during the year-ago period.Profit after tax improved marginally to Rs. 152.27  millions for the quarter ended December 2024 from Rs. 150.98 millions of corresponding previous quarter.The company reported a good operating profit of 283.69 millions compared to 235.01 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1950.19 1622.13 20.22 5571.73 4596.71 21.21 6309.56 5130.83 22.97
Other Income 37.31 31.64 17.92 127.05 90.28 40.73 134.68 99.65 35.15
PBIDT 283.69 235.01 20.71 812.72 651.95 24.66 915.70 702.07 30.43
Interest 14.60 3.05 378.69 30.55 8.27 269.41 11.03 7.86 40.33
PBDT 269.09 231.96 16.01 782.17 643.68 21.52 904.67 694.21 30.32
Depreciation 69.39 33.89 104.75 196.50 99.08 98.32 134.44 123.64 8.74
PBT 199.70 198.07 0.82 585.67 544.60 7.54 770.23 570.57 34.99
TAX 47.43 47.09 0.72 142.03 132.65 7.07 188.79 144.13 30.99
Deferred Tax 8.20 2.39 243.10 5.36 4.42 21.27 15.35 0.63 2336.51
PAT 152.27 150.98 0.85 443.64 411.95 7.69 581.44 426.44 36.35
Equity 104.50 103.99 0.49 104.50 103.99 0.49 103.99 104.63 -0.61
PBIDTM(%) 14.55 14.49 0.41 14.59 14.18 2.84 14.51 13.68 6.06

Windlas Biotech Share Price

1061.45 16.90 (1.62%)
28-Mar-2025 10:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...